CME - Peer-to-Peer Dialogue

EVENT CALENDAR

CHEST Outstanding Educational Activity Award

The France Foundation was the winner of the Clinical Resource Center Outstanding Educational Activity Award in Professional Development at the 2009 American College of CHEST Physicians Annual Meeting.

Learn more >>

PILOT™ STEERING COMMITTEE

Paul W. Noble, MD, Chairperson
Kevin R. Flaherty, MD
Jeffrey A. Golden, MD
Kevin O. Leslie, MD
Steven D. Nathan, MD
Maria L. Padilla, MD
Glenn D. Rosen, MD
Steven A. Sahn, MD
W. Richard Webb, MD

Learn more >>

SHARE WITH A FRIEND

Do you know someone who may be interested in this page? Click the link below:

CME - Peer-to-Peer Dialogue

Peer-to-Peer Dialogue features insightful audio commentary from a multidisciplinary group of experts in interstitial lung disease. Listen in for state-of-the-art information as they address timely, clinically relevant topics identified by the PILOT™ Steering Committee.

Subscribe to Podcast

Download iTunes^®

RSS Feed

PLAY

Question

Faculty

Connective Tissue Disease
	Which CTDs should be included in a differential diagnosis of progressive dyspnea and restrictive lung disease? Click here to access the CME Credit Form CME Activity Expires: November 30, 2011	Maria L. Padilla, MD Steven A. Sahn, MD Charlie Strange, MD
	What are the important serologic markers and when can they appear? Click here to access the CME Credit Form CME Activity Expires: November 30, 2011	Maria L. Padilla, MD Steven A. Sahn, MD Charlie Strange, MD
	Are IPF and CTD mutually exclusive or can they be comorbidities? Click here to access the CME Credit Form CME Activity Expires: November 30, 2011	Maria L. Padilla, MD Steven A. Sahn, MD Charlie Strange, MD
Diagnosis of ILD
	What are the diagnostic criteria for IPF? Click here to access the CME Credit Form CME Activity Expires: September 30, 2011	Kevin O. Leslie, MD Imre Noth, MD Glenn D. Rosen, MD
	What is the clinical profile consistent with IPF? Click here to access the CME Credit Form CME Activity Expires: September 30, 2011	Kevin O. Leslie, MD Imre Noth, MD Glenn D. Rosen, MD
	When should a diagnosis other than IPF be considered with a finding of UIP? Click here to access the CME Credit Form CME Activity Expires: September 30, 2011	Kevin O. Leslie, MD Imre Noth, MD Glenn D. Rosen, MD
Therapy
	Describe the recently completed CAPACITY trials. What were the study designs, results, and implications for clinical practice? Click here to access the CME Credit Form CME Activity Expires: July 31, 2011	Steven D. Nathan, MD Maria L. Padilla, MD Glenn D. Rosen, MD
	What are the current clinical trial enrollment opportunities for therapy of IPF and how should patients be counseled? Click here to access the CME Credit Form CME Activity Expires: July 31, 2011	Steven D. Nathan, MD Maria L. Padilla, MD Glenn D. Rosen, MD
	Are there surrogate primary endpoints for mortality that are valid and are clinically meaningful in clinical trials of IPF patients or is mortality required for pivotal IPF trials? Click here to access the CME Credit Form CME Activity Expires: July 31, 2011	Steven D. Nathan, MD Maria L. Padilla, MD Glenn D. Rosen, MD
Disease Management
	What are the most effective ways to help patients change their lifestyles? Are there preferred tools for smoking cessation, weight loss, diet management, etc? Click here to access the CME Credit Form CME Activity Expires: December 31, 2010	Imre Noth, MD Maria L. Padilla, MD Charlie Strange, MD
	How much do patients want to know about IPF and what are the best sources of information? Click here to access the CME Credit Form CME Activity Expires: December 31, 2010	Imre Noth, MD Maria L. Padilla, MD Charlie Strange, MD
	What are the biggest concerns of patients with IPF and how can we address them? Click here to access the CME Credit Form CME Activity Expires: December 31, 2010	Imre Noth, MD Maria L. Padilla, MD Charlie Strange, MD
Optimal Monitoring of Patients with IPF
	Which tests are the most useful for monitoring IPF? Which are best for assessing the effects of therapy and which are most prognostic? Are there tests that can predict acute exacerbations of IPF? Click here to access the CME Credit Form CME Activity Expires: October 31, 2010	Harold R. Collard, MD Kevin R. Flaherty, MD Steven A. Sahn, MD
	What are the emerging molecular markers which enhance diagnosis or prognosis? Click here to access the CME Credit Form CME Activity Expires: November 30, 2010	Harold R. Collard, MD Kevin R. Flaherty, MD Steven A. Sahn, MD
	What is the role of patient self-assessment in management of IPF and which tools are best? Click here to access the CME Credit Form CME Activity Expires: November 30, 2010	Harold R. Collard, MD Kevin R. Flaherty, MD Steven A. Sahn, MD



For more Peer-to-Peer Dialogue, visit: PILOT™ Peer-to-Peer Archives >>